Brainlab AG recalls ExacTrac 6.0.x Patient Positioning System, Radiation therapy. Intended to be used to place patients at an accurately de…
- Recall date
- August 5, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2440-2015
- FDA classification
- Class II
- Brand / firm
- Brainlab AG
- Sold / distributed
- Worldwide Distribution - USA including the states of AL, AZ, AK, CA CO, CT, FL, GA, ID, IL IN, KY, LA, MD, MA, MI, MN, NE, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, TX, VA, WA, and WI; and, the countries of Australia, Austria, Belgium, Brazil, Canada, China, Denmark, Finland, France, Germany, Hong Ko…
Why it was recalled
ExacTrac 6.0 Patient Positioning System: Display of potentially incorrect Digitally Reconstructed Radiograph (DRR) for x-ray correction and verification.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
ExacTrac 6.0.x Patient Positioning System, Radiation therapy. Intended to be used to place patients at an accurately defined point within the treatment beam of a medical accelerator for stereotactic radiosurgery or radiotherapy procedures.
Get recall alerts
Free email alert whenever Brainlab AG has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Brainlab AG